Advertisement
UK markets close in 5 hours 23 minutes
  • FTSE 100

    7,663.71
    +33.69 (+0.44%)
     
  • FTSE 250

    19,180.63
    +125.76 (+0.66%)
     
  • AIM

    736.39
    -0.11 (-0.01%)
     
  • GBP/EUR

    1.1681
    -0.0001 (-0.00%)
     
  • GBP/USD

    1.2636
    +0.0009 (+0.07%)
     
  • Bitcoin GBP

    49,149.68
    -536.59 (-1.08%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,096.27
    +26.51 (+0.52%)
     
  • DOW

    38,996.39
    +47.37 (+0.12%)
     
  • CRUDE OIL

    79.15
    +0.89 (+1.14%)
     
  • GOLD FUTURES

    2,063.40
    +8.70 (+0.42%)
     
  • NIKKEI 225

    39,910.82
    +744.63 (+1.90%)
     
  • HANG SENG

    16,589.44
    +78.00 (+0.47%)
     
  • DAX

    17,729.05
    +50.86 (+0.29%)
     
  • CAC 40

    7,906.01
    -21.42 (-0.27%)
     

Scholar Rock Holding Third Quarter 2022 Earnings: US$0.55 loss per share (vs US$1.02 loss in 3Q 2021)

Scholar Rock Holding (NASDAQ:SRRK) Third Quarter 2022 Results

Key Financial Results

  • Net loss: US$43.3m (loss widened by 15% from 3Q 2021).

  • US$0.55 loss per share.

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Scholar Rock Holding Earnings Insights

Looking ahead, revenue is forecast to grow 64% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Biotechs industry in the US.

Performance of the American Biotechs industry.

The company's shares are up 16% from a week ago.

Risk Analysis

Before you take the next step you should know about the 3 warning signs for Scholar Rock Holding that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here